Diclofenac Tablets, Suppositories, Injection and Topical Forms
Read the salt, route, release type and full ingredient list before comparing diclofenac products.
Reference table
Diclofenac reference table
The catalogue includes sustained-release tablets, suppositories, injections, transdermal products and combinations. Read the exact salt and ingredient strengths from the pack. A topical product's labelled amount and application instructions cannot be converted to an oral dose by comparing milligram numbers.
Checking route and release form
| Presentation | Specification to record | Main identification question |
|---|---|---|
| Oral tablet | Salt, strength and release type | Does SR or gastro-resistant wording appear? |
| Suppository | Strength per suppository | Is the rectal route prescribed? |
| Injection | Concentration and vial or ampoule volume | Which professional product instructions apply? |
| Topical or transdermal product | Form, strength and pack | What application and duration instructions apply? |
| Combination | Every active ingredient and strength | Which additional precautions apply? |
The source product and country are identified in the article. Confirm personal treatment instructions with the prescribing clinician.
What diclofenac does
Diclofenac is a non-steroidal anti-inflammatory drug used to reduce pain and inflammation in defined conditions. The actual indication, route and course depend on the product and clinical assessment. A persistent painful condition may need diagnosis or treatment review in addition to symptom relief.
The UK MHRA has highlighted the cardiovascular risks of systemic diclofenac. Its advice distinguishes systemic preparations such as tablets, suppositories and injections from topical gels and creams. The lower systemic exposure of a topical preparation does not make every topical product suitable for every person or application site.
Checking route and release form
The catalogue includes sustained-release tablets, suppositories, injections, transdermal products and combinations. Read the exact salt and ingredient strengths from the pack. A topical product's labelled amount and application instructions cannot be converted to an oral dose by comparing milligram numbers.
This table helps identify the requested presentation.
Heart, stomach and kidney safety
Tell the clinician about heart disease, previous stroke, circulation problems, heart failure, high blood pressure, kidney disease and previous ulcers or gastrointestinal bleeding. The MHRA advises assessment of cardiovascular risks when systemic diclofenac is considered.
Use the prescribed course and seek reassessment if the treatment is ineffective or symptoms worsen. Chest pain, stroke-like symptoms, vomiting blood, black stools, severe abdominal pain or serious allergy requires urgent medical assessment. Report new swelling or a substantial change in urine output to the treating team.
Other pain medicines and combinations
Tell the pharmacist about aspirin, anticoagulants, other anti-inflammatory medicines, steroids, blood-pressure medicines and diuretics. Combining pain products can unintentionally duplicate an NSAID or add another active ingredient already being taken.
A diclofenac-paracetamol or diclofenac-muscle-relaxant product has a complete formulation that must be considered together. Follow the exact product leaflet about swallowing, food and administration. Ask before crushing a modified-release tablet or substituting a different dosage form.
A precise diclofenac supply enquiry
Specify the salt where recorded, exact strength, route, release description, brand and manufacturer preference. State the number of units per pack and packs requested. Injection requests should identify both amount per container and container volume so that a concentration is not mistaken for total contents.
Ask for a pack image, current leaflet and relevant manufacturer or batch documents. The receiving organisation should confirm the applicable supply route for that product and destination. The article's UK references describe their own market and do not establish every listed brand's authorisation or clinical interchangeability.
Product information for an enquiry
View Diclofenac 100 mg SR Tablets, Diclofenac 100 mg Suppositories, Diclofenac 75 mg/3 mL Injection for the listed formulations. Include the exact strength, dosage form, quantity and destination in a professional product enquiry.
Export product support
Need product, pack, and documentation details?
Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.
Common questions
Can a gel and tablet be matched by milligrams alone?
The route, formulation, absorption and instructions differ. Use the exact prescribed preparation and its leaflet.
Do suppositories avoid systemic safety checks?
Suppositories deliver systemic diclofenac and remain subject to the relevant cardiovascular, gastrointestinal and renal precautions.
Why mention other pain medicines?
A second medicine may duplicate an NSAID or another ingredient in a combination, increasing adverse-effect or dosing risk.
What does SR mean on a tablet request?
It identifies a sustained-release presentation. Preserve that wording when matching the product and confirm administration instructions with the pharmacist.
Important medical note
This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.